Sangrose Laboratories Pvt Ltd
Sangrose Laboratories Pvt. Ltd. was incorporated in the year 1987 and is the World's Largest Manufacturer of Clofazimine API, along with formulation units for other dosage forms including Tablets, Capsules, Creams, Ointments, and Liquid Orals. We partner with WHO for its Leprosy Eradication Program, and also with the National Leprosy Eradication program for eradicating Leprosy through the supply of both Clofazimine API and capsules.
Sangrose Laboratories has begun drawing its DNA from Mr. C. K. Alexander, an entrepreneur cum research chemist, in the year 1987 to establish as World’s Largest producer of Clofazimine. In fact, it is his spirit of entrepreneurship that has shaped the company to become what it is today.
Mr. C. K. Alexander the Founder and Managing Director was born and brought up in the traditions of Kerala. After acquiring his M.Sc. in Chemistry, he joined a pharmaceutical company and started his career as a chemist. Sheer dint of hard work and determination enabled him to achieve the top management positions in various pharmaceutical majors.
The Master Mind behind the initiation was Mr. C. K. Alexander. Having several decades of experience in the Pharma Industry, blended with entrepreneurial skill triggered him to go ahead with this venture. The company started its production of Clofazimine in the year 1989 with an initial capacity of 1 ton per annum. After that there was no looking back for the Company. The Company attained enhanced production capacity up to 24 tons per annum. The company has been endowed with US FDA approval for the manufacturing quality products.
The company ventured into the domain of formulation development in the year 1994. Then company started off with the Soft Gelatine Encapsulation Unit, which slowly bloomed to include various Formulation Units including Tablet, Hard Gelatine, Liquid Orals, Creams and Ointments. Currently the company has a full-fledged API Manufacturing Unit for Clofazimine I.P., B.P., Ph. Eur., and has a well-equipped Formulation Unit wherein over 300 different formulations are manufactured.
Basic Information
| Nature of Business | Manufacturer |
| Ownership Type | Private Limited Company |
| Company CEO | C.K. Alexander |
| Registered Address | Industrial Estate, Kallimel P.O, , Mavelikara Kerala 690509 |
| Year of Establishment | 1987 |
| Nature of Business | Manufacturer |
| Annual Turnover | Rs. 10 - 25 Crore |
Why Us?
The company draws its strength from its well-established manufacturing capability to deliver products on time with consistent quality. The management’s commitment in adherence to high quality standards, focus on continuous improvement of technology & process, the technology driven Bulk Drug, Capsulation, Tablet, Liquid Orals, Cream and Ointment Unit has been certified as meeting GMP Standards as per WHO Guidelines. Sangrose is constantly improving its production process with Challenging Technologies of the millennium.
The modern manufacturing unit is located in Kerala, and has a well-designed integrated complex built as per the latest GMP specifications.
The state-of-art infrastructure includes – Fluid Bed Processor, Auto-coating machine, Alu blister packing machine, high capacity Automatic mono block Roto fill liquid filling / sealing machine, Labelling and Packing machines etc.
Our Soft Gelatine Capsules have great potential in the domestic and International Markets. We are a constant supplier of Soft Capsules to the Dept of Health Services, Kerala Government. Apart from this, we are having presence in local market also.
Sangrose is also having some potential clients in Sri Lanka, Middle East, Nigeria and U.K for soft capsules and exporting the same to these clients regularly. Therefore, our Marketing Department is having a strong base with domestic and International Marketing practices.
© Sangrose Laboratories Pvt Ltd. All Rights Reserved
